KMTS · Kestra Medical Technologies, Ltd.

$21.57 +0.68 (+3.26%) At close · Jul 23

Market Cap

$1.26B

58.60M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Brian Webster	CEO	$589,098	—	—	$17,889,000	$359,000	$53,632	$18,890,730
Traci S. Umberger	General Counsel	$401,411	—	—	$5,437,050	$179,000	$50,128	$6,067,589
Vaseem Mahboob	CFO	$427,828	—	—	$1,648,830	$187,000	$59,424	$2,323,082

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Brian Webster	CEO	$522,535	—	—	—	$195,951	$39,078	$757,564
Vaseem Mahboob	CFO	$397,515	—	—	—	$119,255	$13,406	$530,176
Traci S. Umberger	General Counsel	$364,395	—	—	—	$109,319	$24,575	$498,289

Key facts CIK 1877184 CUSIP G52441105 13F (30d) 9 filings 9 filers Visit website Investor relations